Primo Vasu Healthcare
BL-77, Sector 116, Noida, Uttar Pradesh 201301, India
https://www.primovasuhealthcare.com/
Primo Vasu Healthcare is a private, multispecialty tertiary-care institution situated on a 22-acre green campus in the quiet suburb of Vasundhara, east-central Bengaluru. Built around an original 1982 mission hospital, the group carried out a phased renewal between 2016 and 2022, doubling bed capacity to 430 and adding five interconnected blocks named after the panchamahabhuta—Prithvi, Jala, Agni, Vayu and Akash—around a landscaped central courtyard that serves as both therapy garden and visitor recharge zone. The buildings are IGBC-Platinum, flood-proof to 500-year storm levels, and host 480kW of rooftop solar backed by lithium-ion storage that reduces grid draw by 62 %.
Clinical services are organised through 12 Centres of Excellence—Cardiac & Vascular, Neurosciences, Maternal-Foetal & Neonatal, Musculoskeletal Cancer, Medical & Surgical Oncology, Women & Child Orthopaedics, Endocrinology & Metabolism, Digestive & Hepatobiliary, Respiratory & Thoracic, Renal & Urological, Digital Dentistry, and Regenerative Rehabilitation. Flagship programmes include a 24/7 STEMI-to-balloon average of 42 minutes (Cardiac Cath Labs in Agni block), a Level-IV NICU with hybrid ECLS, and Karnataka’s first paired-kidney-exchange ABO-incompatible programme. Robotic surgery is anchored by a fourth-generation Versius console in the Akash OT cluster, while the Musculoskeletal Cancer Centre runs India’s only intra-op proton beam service within 12 m of the operating table. Weekend gamma-knife radiosurgery is offered tele-mentored from the Mayo Clinic, shaving patient wait times to 72 h nationally.
Outpatient flow is orchestrated by the VasuCode mobile pass: QR check-in, digital payments, live queue status and multilingual health records reachable through FHIR APIs. The flagship EMR, built on open-source FHIR, automatically calculates a Raman spectrophotometry-based wound-healing index in the Prithvi wound-care pod, adjusting hyperbaric oxygen regimens without consultant keystrokes. A 2023 Joint Commission International re-accreditation cited “zero serious medication errors” across one million doses audited.
Academics and research operate through the Primo Vasu Academy of Translational Sciences, an autonomous unit partnering with IISc and the University of Michigan. The academy runs a 30-seat PhD programme in translational gluco-metabolomics and a 120-resident DNB portfolio. A 48-bed early-phase trials ward supported by an on-site GMP biologics suite has advanced six INDs, including the first allogeneic CAR-T for lupus nephritis now in Phase II. The hospital routinely publishes in NEJM and Lancet, with a 2023 h-index of 112 attributable to its Biobank (70 000 annotated samples).
Community engagement spans three rural health nodes in neighbouring Kolar district, a fleet of nine e-ambulances run by women EMTs, and weekend “Sehat Kiran” pop-up clinics that deliver 170 000 tele-consults a year via a 5G-connected van. The Primo Vasu Foundation underwrites all treatments for children with rare diseases at <5 years of age, a corpus backed by 8 % of the hospital’s annual surplus and funded partly through India’s first green bond issued by a healthcare institution.
Check on Google Maps
- Published: July 29, 2025
